1 | 1CEA |
Plasminogen | Homo sapiens |
P00747 (PLMN_HUMAN) |
6-AMINOHEXANOIC ACID |
ACA |
|
0.86 |
SHOW |
2 | 4CIK |
Plasminogen | Homo sapiens |
P00747 (PLMN_HUMAN) |
5-[(2R,4S)-2-(phenylmethyl)piperidin-4-yl]-1,2-oxazol-3-one |
XO3 |
|
0.78 |
SHOW |
3 | 6DCM |
Tissue-type plasminogen activator | Homo sapiens |
P00750 (TPA_HUMAN) |
6-AMINOHEXANOIC ACID |
ACA |
|
0.73 |
SHOW |
4 | 2PK4 |
Plasminogen | Homo sapiens |
P00747 (PLMN_HUMAN) |
6-AMINOHEXANOIC ACID |
ACA |
|
0.64 |
SHOW |
5 | 4BVD |
Apolipoprotein(a) | Homo sapiens |
P08519 (APOA_HUMAN) |
5-chloro-2-fluoro-N-[1-(4-piperidyl)pyrazol-4-yl]benzenesulfonamide |
BU6 |
|
0.63 |
SHOW |
6 | 4BV7 |
Apolipoprotein(a) | Homo sapiens |
P08519 (APOA_HUMAN) |
3-(4-piperidyl)propanoic acid |
BV7 |
|
0.6 |
SHOW |
7 | 5CSQ |
Hepatocyte growth factor | Homo sapiens |
P14210 (HGF_HUMAN) |
3[N-MORPHOLINO]PROPANE SULFONIC ACID |
MPO |
|
0.59 |
SHOW |
8 | 1GP9 |
Hepatocyte growth factor | Homo sapiens |
P14210 (HGF_HUMAN) |
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID |
EPE |
|
0.54 |
SHOW |
9 | 1PK2 |
Tissue-type plasminogen activator | Homo sapiens |
P00750 (TPA_HUMAN) |
6-AMINOHEXANOIC ACID |
ACA |
|
0.45 |
SHOW |
10 | 6WDV |
Polyamine deacetylase HDAC10 | Danio rerio |
F1QCV2 (HDA10_DANRE) |
4-({3-[(dimethylamino)methyl]-1H-indol-1-yl}methyl)-N-hydroxybenzamide |
TWM |
|
0.42 |
SHOW |
11 | 6WDW |
Polyamine deacetylase HDAC10 | Danio rerio |
F1QCV2 (HDA10_DANRE) |
4-({3-[2-(dimethylamino)ethyl]-1H-indol-1-yl}methyl)-N-hydroxybenzamide |
TWV |
|
0.41 |
SHOW |